Indeed, all three PPAR subtypes share common lipid-lowering properties [25–28], and PPARα [29–32] and PPARγ [33–36] exert similar renoprotective effects in animals or humans with diabetic nephropathy. The gene discussed is PPARG; the disease is diabetic kidney disease.